Ratio of Metalloproteinase 2 to Tissue Inhibitor of Metalloproteinase 2 in Medullary Thyroid CarcinomaGODOI CAVALHEIRO, Beatriz; RODRIGUES JUNQUEIRA, Consuelo; GARCIA BRANDDO, Lenine et al.Archives of otolaryngology, head & neck surgery. 2009, Vol 135, Num 8, pp 812-817, issn 0886-4470, 6 p.Article

Medullary thyroid carcinomaCOHEN, Erik G; SHAHA, Ashok R; RINALDO, Alessandra et al.Acta oto-laryngologica. 2004, Vol 124, Num 5, pp 544-557, issn 0001-6489, 14 p.Article

Carcinome médullaire typique du sein : étude rétrospective à propos de 33 cas = Typical medullary carcinoma of the breast : A retrospective study about 33 casesKHOMSI, F; BEN BACHOUCHE, W; GAMOUDI, A et al.Gynécologie obstétrique & fertilité. 2007, Vol 35, Num 11, pp 1117-1122, issn 1297-9589, 6 p.Article

mTOR activation in medullary thyroid carcinoma with RAS mutationLYRA, Joana; VINAGRE, João; BATISTA, Rui et al.European journal of endocrinology. 2014, Vol 171, Num 5, pp 633-640, issn 0804-4643, 8 p.Article

Renal Medullary Carcinoma : The Bronx ExperienceARI HAKIMI, A; KOL, Phillip T; MILHOUA, Paul M et al.Urology (Ridgewood, NJ). 2007, Vol 70, Num 5, pp 878-882, issn 0090-4295, 5 p.Article

Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech RepublicJINDRICHOVA, S; VCELAK, J; VLCEK, P et al.Journal of endocrinology. 2004, Vol 183, Num 2, pp 257-265, issn 0022-0795, 9 p.Article

WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary typeUGOLINI, Francoise; CHARAFE-JAUFFRET, Emmanuelle; PEBUSQUE, Marie-Josèphe et al.Oncogene (Basingstoke). 2001, Vol 20, Num 41, pp 5810-5817, issn 0950-9232Article

Medullary carcinoma of the thyroid : Subtypes and current managementRANDOLPH, G. W.Comprehensive therapy. 1996, Vol 22, Num 4, pp 203-210, issn 0098-8243Article

Clinical manifestations of familial medullary thyroid carcinomaKAMEYAMA, Kaori; OKINAGA, Hiroko; TAKAMI, Hiroshi et al.Biomedicine & pharmacotherapy. 2004, Vol 58, Num 6-7, pp 348-350, issn 0753-3322, 3 p.Article

Medullary thyroid carcinoma: a rare presentation as a hypervascular tumourLI, W. Y; TOMLINSON, M. A; BRYSON, J. M et al.Journal of laryngology and otology. 2002, Vol 116, Num 8, pp 647-649, issn 0022-2151Article

Le cancer médullaire de la thyroïde = Medullary thyroid carcinomaMURAT, Arnaud; NICOLLI-SIRE, Patricia.MTE. Médecine thérapeutique endocrinologie. 2000, Vol 2, Num 5, pp 430-437, issn 1295-9359Article

The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiationDILLA, Tatiana; ROMERO, Jesus; SANSTISTEBAN, Pilar et al.Oncogene (Basingstoke). 2002, Vol 21, Num 15, pp 2376-2386, issn 0950-9232, 11 p.Article

A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relativesSIGNORINI, Priscila S; FRANCA, Maria Inez C; CERUTTI, Janete M et al.Clinical endocrinology (Oxford. Print). 2014, Vol 80, Num 2, pp 235-245, issn 0300-0664, 11 p.Article

Renal medullary carcinomaSTEELE, Erica L; MACLENNAN, Gregory T.The Journal of urology. 2005, Vol 174, Num 4, issn 0022-5347, p. 1449, 1Article

Expression of CD97 and CD55 in human medullary thyroid carcinomasMUSTAFA, Tarek; KLONISCH, Thomas; HOMBACH-KLONISCH, Sabine et al.International journal of oncology. 2004, Vol 24, Num 2, pp 285-294, issn 1019-6439, 10 p.Article

Medullary thyroid carcinomaLEBOULLEUX, Sophie; BAUDIN, Eric; TRAVAGLI, Jean-Paul et al.Clinical endocrinology (Oxford. Print). 2004, Vol 61, Num 3, pp 299-310, issn 0300-0664, 12 p.Article

Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas : Different spectrum of mutations in sporadic type from hereditary typeUCHINO, S; NOGUCHI, S; TAKAHASHI, M et al.Japanese journal of cancer research. 1999, Vol 90, Num 11, pp 1231-1237, issn 0910-5050Article

Advances and controversies in the diagnosis and management of medullary thyroid carcinomaHESHMATI, H. M; GHARIB, H; VAN HEERDEN, J. A et al.The American journal of medicine. 1997, Vol 103, Num 1, pp 60-69, issn 0002-9343Article

Les hypercalcitoninémies en dehors des cancers médullaires de la thyroïde = Hypercalcitoninemia out of medullary thyroid carcinomaNICCOLI, P; CONTE-DEVOLX, B; LEJEUNE, P. J et al.Annales d'endocrinologie. 1996, Vol 57, Num 1, pp 15-21, issn 0003-4266Conference Paper

Place des thérapeutiques non chirurgicales dans le traitement des patients atteints de cancer médullaire de la thyroïde = The place of non surgical therapeutics in the management of patients suffering from medullary thyroid carcinomaGULIANA, J. M.Annales d'endocrinologie. 1996, Vol 57, Num 1, pp 33-40, issn 0003-4266Conference Paper

Pentavalent ⁹⁹Tc^m-DMSA imaging in patients with bone metastasesLAM, A. S. K; KETTLE, A. G; O'DOHERTY, M. J et al.Nuclear medicine communications. 1997, Vol 18, Num 10, pp 907-914, issn 0143-3636Conference Paper

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomaMARSH, D. J; LEAROYD, D. L; ANDREW, S. D et al.Clinical endocrinology (Oxford. Print). 1996, Vol 44, Num 3, pp 249-257, issn 0300-0664Article

Le cancer médullaire de la thyroïde : Tumeurs du corps thyroïde = Medullary thyroid cancer : Thyroid tumoursMODIGLIANI, E.La Revue du praticien (Paris). 1996, Vol 46, Num 19, pp 2303-2308, issn 0035-2640Article

Le cas clinique du mois : intérêt du test à la pentagastrine dans la détection précoce d'un cancer médullaire de la thyroïde = Pentagastrine test in thyroid medullary cancerLEGROS, J.-J; BECKERS, V; MILET, J et al.RMLG. Revue médicale de Liège. 1995, Vol 50, Num 12, pp 499-500, issn 0370-629XArticle

Analysis of DNA mismatch repair proteins in human medulloblastomaLEE, S. E; JOHNSON, S. P; FRIEDMAN, H. S et al.Clinical cancer research. 1998, Vol 4, Num 6, pp 1415-1419, issn 1078-0432Article